CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SIGHTED aims to create a neural implant that restores vision for blind patients. The project will refine a prototype to prepare for human testing, focusing on regulatory approval and commercial strategies for its innovative technology.
SIGHTED aims to deliver a breakthrough neural implant to restore functional vision in patients who have lost their sight, enabling them to regain autonomy.
Building on the ongoing FET-Open NeuraViPeR project (https://www.neuraviper.eu/), which concludes in February 2025, SIGHTED will advance our proof-of-concept prototype (TRL 3) to a fully validated implant ready for human testing (TRL 5).
Concurrently, we will prepare for commercial adoption by securing regulatory clearance to initiate a First…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Paris
Type: Research institute
Activity type: Research Organisations
SME: No
Netherlands, AMSTERDAM
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
